Bittium Faros Pro Long-Term Ambulatory ECG System

Bittium is a Finnish technology company headquartered in Oulu and listed on Nasdaq Helsinki, with a 40-year legacy in radio communications and a medical business, Bittium Biosignals, based in Kuopio, that develops biosignal measurement for cardiology and neurology. It addresses the problem that short Holter tests miss intermittent arrhythmias such as atrial fibrillation, which is linked to around one in five clot-related strokes.

Bittium Faros Pro is an MDR-certified, IP67 waterproof 1-, 2- or 3-channel ECG recorder that records from 24 hours up to 30 days, with up to 21 days of battery, sampling up to 1000 Hz and up to 90 days of memory, worn with EasyFlex one-lead patches. Recordings flow into Bittium Cardiac Navigator for automated noise detection, rhythm review and reports, and Bittium MedicalSuite for secure sharing. Customers are hospitals, clinics, cardiac monitoring service providers and researchers.

• Faros Pro recorder: MDR-certified 1-, 2- or 3-channel ECG for 24 hours to 30 days.
• Long battery and memory: up to 21 days on a single charge and up to 90 days of memory.
• EasyFlex patches: single-use one-lead electrode patches for comfortable everyday wear.
• Cardiac Navigator: ECG analysis software with automated noise detection and clinical-ready reports.
• MedicalSuite: web-based platform for secure sharing and collaborative cardiac and sleep apnea care.
• Open data: EDF format, Bluetooth and Hi-Speed USB transfer for integration workflows.

Stroke units in Vietnamese hospitals could use 14 to 30 day Faros Pro recordings to find atrial fibrillation after cryptogenic stroke. Cardiac diagnostic service companies could build centralised reading services with Cardiac Navigator for multiple clinics. Clinical research organisations could use the open data format for cardiac safety endpoints.

Longer monitoring catches more arrhythmias: the company cites evidence that 49 hours of monitoring finds only 11-59% of arrhythmias detected in 30 days, while 14 days finds 71-93%. One reusable device covers Holter, long-term and event monitoring use cases with no in-hospital maintenance. Waterproof design and light patches let patients shower and exercise during recording. Open EDF data format and software integration support service providers building centralised reading services.

Stroke prevention guidelines increasingly favour extended ambulatory ECG monitoring over 24-hour Holter to detect silent atrial fibrillation. Stroke is a leading cause of death and disability in Vietnam, and cardiology centres face growing demand for arrhythmia testing while needing equipment that supports centralised reading and remote services.

Headquartered in Oulu, Finland, and listed on Nasdaq Helsinki; net sales in 2025 were EUR 119.3 million. Medical business is run by Bittium Biosignals Ltd. in Kuopio, with offices in the USA, Germany and the UK. Bittium reports Faros devices in 40+ countries, 300+ clinical studies and 600,000+ devices delivered. Faros Pro is MDR certified.